GAC

1.

Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says

13 Dec 2017
The reason? “Limitations of budgets in the 2017-2019 allocations period”
GAC calls for urgent inter-agency discussions, with donor governments included

In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation

2.

Board approves third batch of Global Fund grants valued at $2.83 billion

12 Dec 2017
Sixty-two grants from 29 countries were approved

On 1 December 2017, the Global Fund Board approved grants worth $2.83 billion from the 2017-2019 allocations. This is the largest amount approved in a single batch since the start of the new funding model.

1.

Global Fund Board approves a second batch of grants for 2017-2019

28 Nov 2017
Twenty funding requests yielded 32 grants
14.

Philippines’ HIV funding request to the Global Fund contains a good mix of prevention and treatment: TRP

7 Nov 2017
However, the country’s matching funds request was sent back for iteration

The Philippines’ HIV funding request was strategically focused with appropriately targeted investments towards HIV prevention programs for key populations, and access to testing and treatment services. This was the conclusion of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) when they reviewed the request.

12.

Bangladesh’s “ambitious, but realistic” TB funding request to the Global Fund receives positive reviews

6 Nov 2017
The two grants will expand case finding interventions, upgrade diagnostics and scale-up a public-private mix approach to TB

The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.

9.

Global Fund expresses concern over Benin’s plan to shift funds away from HIV and malaria towards an RSSH funding request

23 Oct 2017
Secretariat decides to leave program split decision open until the RSSH proposal is received
Size of salary incentives linked to grant performance ratings

When it reviewed the funding requests from Benin, the Grant Approvals Committee (GAC) and the Technical Review Panel (TRP) expressed serious concerns about what they perceived as gaps in Benin’s HIV and malaria programs – which, they said, were partly due to the decision of the country coordinating mechanism (CCM) to shift some of its allocation towards an RSSH funding request.

The original allocation for Benin was as follows:

8.

Malawi’s TB/HIV grants approved by the Global Fund do not differ much from the funding request

23 Oct 2017
The TRP requested only minimal clarifications

The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.

10.

Global Fund provides update on incentive funding awarded to Nigeria and India

23 Oct 2017
The awards were conditional on the recipient countries coming up with matching funds

The Secretariat has reported on developments concerning incentive funding awarded to Nigeria and India as part of the 2014-2016 allocations. The updates were contained in the latest report of the Grant Approvals Committee to the Board.

Nigeria

7.

Zimbabwe’s new Global Fund grants for TB/HIV are clearly aligned to the country’s epi profile and its national strategic plans, TRP says

17 Oct 2017
Grants include a strong focus on interventions targeting key populations

In their recommendation to the Board on Zimbabwe’s TB/HIV funding request, the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC) commented favorably on Zimbabwe’s inclusion of interventions to address barriers related to human rights and gender, and its focus on key populations for HIV, TB and STI care and treatment.

6.

Global Fund Board approves grants totaling more than $2 billion

17 Oct 2017
Thirty-two funding requests were processed in less than seven months

Pages

Subscribe to GAC